Condition
CLDN18.2 Positive clinical trials and research
As of November 12, 2026, Find a Trial lists 2 CLDN18.2 Positive clinical trials that are recruiting, in China. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
IBI343 with sintilimab and SOX before and during surgery for resectable locally advanced gastric or GEJ cancer
A phase II trial tests whether adding IBI343 to sintilimab plus a SOX chemotherapy regimen around surgery helps people with CLDN18.2-positive, locally advanced gastric or GEJ cancer who are candidates for curative D2 surgery.
-
IBI343 in combination with chemotherapy for CLDN18.2-positive gastric cancer and pancreatic cancer
This study tests whether adding IBI343 to standard chemotherapy helps people with CLDN18.2-positive advanced gastric/gastroesophageal junction cancer or pancreatic ductal cancer.
Related topics
Quick answers
How many CLDN18.2 Positive clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.